Association of total bilirubin and indirect bilirubin content with metabolic syndrome among Kazakhs in Xinjiang

BMC Endocrine Disorders

Table 3 Analysis of influencing factors for incident metabolic syndrome

Parameter	n	MS,n(%)	HR	95%CI	P
TBIL
Q1	139	46 (33.1)	ref	ref	ref
Q2	141	50 (35.5)	0.47	0.31–0.71	< 0.001
Q3	143	53 (37.1)	0.53	0.35–0.79	0.002
Q4	142	55 (38.7)	0.48	0.32–0.72	< 0.001
IBIL
Q1	140	46 (32.9)	ref	ref	ref
Q2	141	48 (34.0)	0.48	0.32–0.72	< 0.001
Q3	139	53 (38.1)	0.54	0.36–0.81	0.003
Q4	145	57 (39.3)	0.52	0.35–0.77	0.001
DBIL
Q1	133	43 (32.3)	ref	ref	ref
Q2	135	54 (40.0)	1.23	0.82–1.84	0.320
Q3	150	56 (37.3)	1.32	0.88–1.96	0.178
Q4	147	51 (34.7)	0.88	0.58–1.32	0.531
ALT
Q1	115	33 (28.7)	ref	ref	ref
Q2	194	68 (35.1)	0.99	0.65–1.50	0.949
Q3	131	55 (42.0)	1.06	0.69–1.63	0.806
Q4	125	48 (38.4)	1.04	0.67–1.62	0.857
AST
Q1	130	44 (33.8)	ref	ref	ref
Q2	159	69 (43.4)	0.76	0.52–1.12	0.169
Q3	136	49 (36.0)	0.70	0.47–1.06	0.091
Q4	140	42 (30.0)	0.86	0.56–1.31	0.475

ISSN: 1472-6823